In conclusion, despite the restriction of this study to a limited population, the results suggest that the TT genotype of the rs10046 polymorphism in the CYP19 gene is associated with a higher relative breast cancer incidence in premenopausal patients. Here, CYP19A1 is linked to breast carcinoma.